Oscar Lin
Impact in
- Oncology top 2%
- Viral-associated cancers and disorders
- Cancer Cells and Metastasis
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Co-authors
- Ronald Ghossein (8 shared papers)Richard R. Barakat (8 shared papers)Ashok R. Shaha (6 shared papers)Martin Fleisher (5 shared papers)Glauco Frizzera (2 shared papers)Maureen F. Zakowski (11 shared papers)Richard J. Wong (5 shared papers)Julie Teruya‐Feldstein (6 shared papers)
- Journals
- Diagnostic Cytopathology (19 papers)Cancer Cytopathology (13 papers)Cancer (12 papers)Acta Cytologica (10 papers)Archives of Pathology & Laboratory Medicine (6 papers)
- Partner nations
- United StatesPortugalFrance
In The Last Decade
Oscar Lin
142 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 99
- Oncology 1.2k
- Reproductive Medicine 367
- Endocrinology, Diabetes and Metabolism 713
- Obstetrics and Gynecology 312
- Cancer Research 454
Countries citing papers authored by Oscar Lin
This map shows the geographic impact of Oscar Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar Lin more than expected).
Fields of papers citing papers by Oscar Lin
This network shows the impact of papers produced by Oscar Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar Lin. The network helps show where Oscar Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Oscar Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 290 | |
| 2 | 2007 | 284 | |
| 3 | 2004 | 158 | |
| 4 | 2003 | 158 | |
| 5 | 2009 | 152 | |
| 6 | 2001 | 106 | |
| 7 | 2015 | 101 | |
| 8 | 2001 | 101 | |
| 9 | 2004 | 97 | |
| 10 | 1997 | 96 | |
| 11 | 2017 | 90 | |
| 12 | 2002 | 88 | |
| 13 | 2013 | 84 | |
| 14 | 2012 | 82 | |
| 15 | 2016 | 79 | |
| 16 | 2010 | 79 | |
| 17 | 2020 | 74 | |
| 18 | 2011 | 73 | |
| 19 | 2016 | 70 | |
| 20 | 2003 | 69 |
About Oscar Lin
Oscar Lin is a scholar working on Surgery, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 151 papers that have together received 4.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (16 papers), Salivary Gland Tumors Diagnosis and Treatment (14 papers), Thyroid Cancer Diagnosis and Treatment (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Cervical Cancer and HPV Research (10 papers), AI in cancer detection (10 papers), Neuroendocrine Tumor Research Advances (8 papers) and Viral-associated cancers and disorders (7 papers). The work is most often cited by research in Oncology (1.2k citations), Reproductive Medicine (367 citations), Endocrinology, Diabetes and Metabolism (713 citations), Obstetrics and Gynecology (312 citations) and Cancer Research (454 citations). Oscar Lin has collaborated with scholars based in United States, Portugal and France. Frequent co-authors include Ronald Ghossein, Richard R. Barakat, Ashok R. Shaha, Martin Fleisher, Glauco Frizzera, Maureen F. Zakowski, Richard J. Wong, Julie Teruya‐Feldstein, Rita Gonzalez-Espinoza and Marina Cardillo. Their work appears in journals such as Diagnostic Cytopathology, Cancer Cytopathology, Cancer, Acta Cytologica and Archives of Pathology & Laboratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.